Zobrazeno 1 - 5
of 5
pro vyhledávání: '"N. B. Kovaleva"'
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 28, Iss 1, Pp 41-49 (2018)
Aim of the study. To estimate efficacy and safety of cepeginterferon-alpha 2b (cPEG-IFNα2b) and ribavirin combination for the treatment of chronic hepatitis C (CHC), to define necessity of IL-28V genetic polymorphism diagnostics, to estimate liver e
Externí odkaz:
https://doaj.org/article/7ea32df125df4efc9eebb813ba138295
Autor:
N. B. Kovaleva
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 24, Iss 2, Pp 65-68 (2014)
Aim of investigation. To study efficacy and safety of domestic recombinant interferon α-2b Altevir® in combination to ribavirin in previously untreated patients with chronic hepatitis C (CHC).Material and methods. Retrospective treatment results ra
Externí odkaz:
https://doaj.org/article/d4a8e827e95a4594af546981410dc774
Publikováno v:
Problemy endokrinologii. 29(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c90cafe17d8b0490445c084dad6118e
https://pubmed.ncbi.nlm.nih.gov/6403936
https://pubmed.ncbi.nlm.nih.gov/6403936
Autor:
N S, Mazalova, N B, Kovaleva
Publikováno v:
Klinicheskaia meditsina. 64(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46b2cbdb1bdb57e96a2d1f0ab7b46fc0
https://pubmed.ncbi.nlm.nih.gov/3784468
https://pubmed.ncbi.nlm.nih.gov/3784468
Autor:
N B, Kovaleva
Publikováno v:
Klinicheskaia meditsina. 53(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96f334a70d2962a2cea5acd182710808
https://pubmed.ncbi.nlm.nih.gov/1117667
https://pubmed.ncbi.nlm.nih.gov/1117667